- Strong match: 3 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
Back to StakeholdersCentre of the Heart Mindspace Florida International University University of Pennsylvania
Categories
2 domains / 4 areas / 3 specializations
SCPTR
Data updated
United States
Salt City Psychedelic Therapy and Research (SCPTR) is a Utah-based nonprofit serving the Intermountain West, with a U.S. headquarters and regional focus. It was founded by the late Dr. Parth Gandhi and is described as advancing psychedelic-assisted therapy through education, research, and advocacy.
SCPTR’s field role is centered on public education, practitioner and researcher support, and regional policy reform around psychedelic-assisted therapy. Publicly documented activity includes organizing the annual Intermountain Psychedelic Symposium, which has been described as a venue for learning, networking, harm reduction, and local fundraising for clinical trials in Utah.
IntroductoryHybridMid costPsychedelic-assisted therapy trainingHarm reductionContinuing educationOtherLicensed cliniciansAspiring practitionersOther
Blossom’s read
SCPTR looks like a small, regionally rooted psychedelic-therapy educator rather than a large commercial training brand. The strongest public evidence points to an 8-week ketamine-leaning clinician course, with clinical, ethical and research basics and some notable lineage through MAPS and CIIS faculty references. Reputation-wise, it seems to have had a real local footprint in Utah, but the programme is now reported as no longer live, and there is little independently verifiable student-review material beyond a few practitioner mentions.
Who SCPTR is for
Best suited to mental health or allied professionals who want an introductory, practice-facing grounding in psychedelic-assisted therapy, especially ketamine and broader psychedelic harm reduction and ethics. It also appears relevant to people seeking regional professional community rather than a standalone formal qualification.
Prerequisites
No firm prerequisite list was found on the public sources consulted. The course is described as aimed at aspiring therapists and healers, and secondary references frame it as a professional development programme for clinicians, but explicit licensure or entry conditions were not verifiable.
Accreditation & recognition
Blossom’s course listing identifies CE, not CME. I could not verify any formal licensure, board certification, or regulator-approved psychedelics credential from SCPTR itself in the sources found.
Cost
Blossom’s course listing gives a cost of 1925 for the programme. The conserved course description says the training included live Zoom sessions, weekly process groups, and optional one-to-one integration sessions; however, an exact inclusion breakdown from SCPTR itself was not verifiable.
What you walk away with
Learners appear to walk away with an introductory understanding of psychedelic-assisted therapy, including harm reduction, ethics, research, and modality-specific exposure to MDMA, psilocybin, and ketamine-assisted psychotherapy. The practical outcome seems to be professional readiness and regional network-building rather than a clearly stated formal credential.
Similar course providers
Reference points selected from shared training modalities, learner audience, level, delivery format, pricing, and location.
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 2 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
- Strong match: 2 shared modalities
- Strong match: 3 shared learner audiences
- Also shares: introductory level
- Also shares: hybrid delivery
Quick Facts
- Type
- Non-Profit
- HQ
- United States
- Website
- Visit